Researchers sought to determine the effect of long-term opioid exposure on esophageal motility, using a large cohort. Dysphagia occurs in nearly 2 of 3 individuals receiving treatment with opioids and ...

Panel A shows the microscopic myoarchitecture of the circular and longitudinal muscle layers of the lower esophageal sphincter and stomach. The circular muscle fibers of the esophagus cross each other ...

Investigators wanted to assess endoscopic appearance, wall thickness, histology, and dysphagia score for eosinophilic esophagitis (EoE). Patients who have eosinophilic esophagitis (EoE) developed ...

Barrett's esophagus (BE) is one of the most common premalignant lesions and can progress to esophageal adenocarcinoma. It is characterized histologically by a specialized intestinal metaplasia that ...

This is a preview. Log in through your library . Abstract The esophagus, like other luminal organs of the digestive system, provides a potential environment for bacterial colonization, but little is ...

S-1 and intraperitoneal and intravenous paclitaxel as neoadjuvant chemotherapy for gastric cancer with positive peritoneal cytology. Background: There is limited data comparing intensity modulated ...

Outcome of the nonrandomized patients in the FFCD 9102 trial: Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus No significant financial ...

The assumption that intestinal metaplasia is a prerequisite for intraepithelial neoplasia/dysplasia and adenocarcinoma in the distal esophagus has been challenged by observations of adenocarcinoma ...

PROLONGED gastric intubation may be a factor in the development of peptic esophagitis and stricture in some patients, but whether acid reflux into the esophagus is the primary mechanism is uncertain.

Esophagus stomach The researchers found that for discriminating BE-related metaplasia and neoplasia cases versus normal individuals, CCNA1 DNA methylation had an area under the curve of 0.95, which ...

PAVmed has licensed a device to detect a precursor to esophageal cancer and set up a subsidiary to take it to market. The subsidiary, Lucid Diagnostics, hopes to start selling the device in the U.S.